Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Elevated Vancomycin Trough Levels in a Tertiary Health System: Frequency, Risk Factors, and Prognosis.

Zonozi R, Wu A, Shin JI, Secora A, Coresh J, Inker LA, Chang AR, Grams ME.

Mayo Clin Proc. 2019 Jan;94(1):17-26. doi: 10.1016/j.mayocp.2018.08.034.

PMID:
30611444
2.

Commentary on "Methodologic limitations of prescription opioid safety research and recommendations for improving the evidence base".

Staffa J, Meyer T, Secora A, McAninch J.

Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):13-15. doi: 10.1002/pds.4650. Epub 2018 Sep 17. No abstract available.

PMID:
30221420
3.

Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults.

Secora A, Alexander GC, Ballew SH, Coresh J, Grams ME.

Drugs Aging. 2018 Aug;35(8):735-750. doi: 10.1007/s40266-018-0563-1.

4.

Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation.

Shin JI, Secora A, Alexander GC, Inker LA, Coresh J, Chang AR, Grams ME.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1144-1152. doi: 10.2215/CJN.13811217. Epub 2018 Jul 12.

5.

Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study.

Lazarus B, Wu A, Shin JI, Sang Y, Alexander GC, Secora A, Inker LA, Coresh J, Chang AR, Grams ME.

JAMA Intern Med. 2018 Jul 1;178(7):903-910. doi: 10.1001/jamainternmed.2018.0292.

6.

Opioid analgesic dose and the risk of misuse, overdose, and death: A narrative review.

Coyle DT, Pratt CY, Ocran-Appiah J, Secora A, Kornegay C, Staffa J.

Pharmacoepidemiol Drug Saf. 2018 May;27(5):464-472. doi: 10.1002/pds.4366. Epub 2017 Dec 15. Review.

PMID:
29243305
7.

Important statistical considerations in the evaluation of post-market studies to assess whether opioids with abuse-deterrent properties result in reduced abuse in the community.

By K, McAninch JK, Keeton SL, Secora A, Kornegay CJ, Hwang CS, Ly T, Levenson MS.

Pharmacoepidemiol Drug Saf. 2018 May;27(5):473-478. doi: 10.1002/pds.4287. Epub 2017 Aug 23.

PMID:
28833803
8.

Drug availability adjustments in population-based studies of prescription opioid abuse.

Secora A, Trinidad JP, Zhang R, Gill R, Dal Pan G.

Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):180-191. doi: 10.1002/pds.4139. Epub 2016 Dec 21.

PMID:
28000295
9.

Measures to quantify the abuse of prescription opioids: a review of data sources and metrics.

Secora AM, Dormitzer CM, Staffa JA, Dal Pan GJ.

Pharmacoepidemiol Drug Saf. 2014 Dec;23(12):1227-37. doi: 10.1002/pds.3711. Epub 2014 Sep 25. Review.

PMID:
25257660
10.

A comparison of psychosocial and cognitive functioning between depressed and non-depressed patients with cannabis dependence.

Secora AM, Eddie D, Wyman BJ, Brooks DJ, Mariani JJ, Levin FR.

J Addict Dis. 2010 Jul;29(3):325-37. doi: 10.1080/10550887.2010.489444.

11.

Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial.

Levin FR, Mariani JJ, Secora A, Brooks D, Cheng WY, Bisaga A, Nunes E, Aharonovich E, Raby W, Hennessy G.

J Dual Diagn. 2009 Jan 1;5(1):41-56.

Supplemental Content

Loading ...
Support Center